Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-03

Clinical Trial Update: Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)

View source ↗

Summary

The AXAES trial evaluating correlation between LR-ACT and anti-Xa activity during endovascular procedures was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Aortic Diseases, Arterial Disease | Status: WITHDRAWN